Treatment News : Researchers Engineer HIV-Killing Cells From Stem Cells

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » December 2009

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


December 8, 2009

Researchers Engineer HIV-Killing Cells From Stem Cells

Researchers at the University of California in Los Angeles (UCLA) have demonstrated it is possible to engineer new HIV-specific killer CD8 cells from stem cells in the blood, according to an announcement by UCLA. The novel treatment approach, introduced in December in PLoS One, has a long way to go before it could be tested in humans, but it shows promise to fight other illnesses in addition to HIV/AIDS.

People who are naturally able to control HIV for long periods of time have high numbers of a type of an immune cell known as a cytotoxic T-lymphocyte (CTL) that is specific to HIV. Conversely, low levels of HIV-specific CTLs have been associated with more rapid disease progression. Researchers have attempted to increase a person’s HIV-specific CTL numbers by expanding the population of cells outside the body and then reinfusing them, but this process didn’t work because the cells did not live long and function fully.

To determine whether it might be possible to generate a large population of fully functional and long-lived HIV-specific CTLs, Scott Kitchen, PhD, and his colleagues at UCLA cloned a T-cell receptor from an HIV-specific CTL and then used it to engineer human stem cells that could fight HIV. The new HIV-specific CTLs were grown in human thymus tissue implanted in specially bred mice.

Kitchen’s team found that the cells lived long, reproduced and appeared to recognize HIV.

Challenges remain, however. First, according to Kitchen and his colleagues, expanded CTLs will have to be cloned and expanded for each individual, a time-consuming and costly process. One person’s CTLs cannot be used in another person. Second, because HIV can escape existing CTLs by mutating, it might be necessary to expand a variety of CTL populations in an individual in order to control HIV. Third, researchers must next demonstrate in more sophisticated models whether it is possible to engineer functional cells that can reproduce and thrive in humans.

Despite these challenges, the team is encouraged by this initial success. “This approach could be used to combat a variety of chronic viral diseases,” said study coauthor and fellow UCLA professor Jerome Zack, PhD. “It’s like a genetic vaccine.”

Search: Stem cells, cytotoxic T-lymphocytes, CTL, CD8, killer cells, Scott Kitchen, Jerome Zack

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (4 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Has a pet helped you deal with your HIV?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.